176 related articles for article (PubMed ID: 10668699)
1. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice.
Limoges J; Persidsky Y; Poluektova L; Rasmussen J; Ratanasuwan W; Zelivyanskaya M; McClernon DR; Lanier ER; Gendelman HE
Neurology; 2000 Jan; 54(2):379-89. PubMed ID: 10668699
[TBL] [Abstract][Full Text] [Related]
2. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.
Spitzenberger TJ; Heilman D; Diekmann C; Batrakova EV; Kabanov AV; Gendelman HE; Elmquist WF; Persidsky Y
J Cereb Blood Flow Metab; 2007 May; 27(5):1033-42. PubMed ID: 17063148
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human immunodeficiency virus replication in human brain tissue by nucleoside reverse transcriptase inhibitors.
Kandanearatchi A; Vyakarnam A; Landau S; Everall IP
J Neurovirol; 2004 Apr; 10(2):136-9. PubMed ID: 15204933
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR
Ann Neurol; 2005 Jun; 57(6):795-803. PubMed ID: 15852478
[TBL] [Abstract][Full Text] [Related]
5. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
[TBL] [Abstract][Full Text] [Related]
6. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility of retroviruses to nucleoside analogues.
Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
Picard V; Angelini E; Maillard A; Race E; Clavel F; Chêne G; Ferchal F; Molina JM
J Infect Dis; 2001 Sep; 184(6):781-4. PubMed ID: 11517441
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
[TBL] [Abstract][Full Text] [Related]
10. Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.
Senanayake TH; Gorantla S; Makarov E; Lu Y; Warren G; Vinogradov SV
Mol Pharm; 2015 Dec; 12(12):4226-36. PubMed ID: 26565115
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication.
Bisset LR; Lutz H; Böni J; Hofmann-Lehmann R; Lüthy R; Schüpbach J
Antiviral Res; 2002 Jan; 53(1):35-45. PubMed ID: 11684314
[TBL] [Abstract][Full Text] [Related]
12. The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
Gray LR; Tachedjian G; Ellett AM; Roche MJ; Cheng WJ; Guillemin GJ; Brew BJ; Turville SG; Wesselingh SL; Gorry PR; Churchill MJ
PLoS One; 2013; 8(4):e62196. PubMed ID: 23614033
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
14. Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.
Bradshaw D; Malik S; Booth C; Van Houtte M; Pattery T; Waters A; Ainsworth J; Geretti AM
Antimicrob Agents Chemother; 2007 Dec; 51(12):4489-91. PubMed ID: 17876005
[TBL] [Abstract][Full Text] [Related]
15. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
Nitanda T; Wang X; Somekawa K; Yuasa S; Baba M
Antivir Chem Chemother; 2001 May; 12(3):161-7. PubMed ID: 12959324
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus encephalitis in SCID mice.
Persidsky Y; Limoges J; McComb R; Bock P; Baldwin T; Tyor W; Patil A; Nottet HS; Epstein L; Gelbard H; Flanagan E; Reinhard J; Pirruccello SJ; Gendelman HE
Am J Pathol; 1996 Sep; 149(3):1027-53. PubMed ID: 8780406
[TBL] [Abstract][Full Text] [Related]
17. The nucleoside reverse transcriptase inhibitors didanosine, lamivudine, stavudine and zidovudine show little effect on the virulence of Candida albicans in vitro.
Ahmadou Ahidjo B; Veale R; Dusé AG; Becker P; Marais E
Int J Antimicrob Agents; 2008 Aug; 32(2):186-91. PubMed ID: 18571385
[TBL] [Abstract][Full Text] [Related]
18. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.
Saavedra-Lozano J; McCoig CC; Cao Y; Vitetta ES; Ramilo O
Antimicrob Agents Chemother; 2004 Aug; 48(8):2825-30. PubMed ID: 15273087
[TBL] [Abstract][Full Text] [Related]
20. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons.
Zhang Y; Song F; Gao Z; Ding W; Qiao L; Yang S; Chen X; Jin R; Chen D
PLoS One; 2014; 9(1):e85637. PubMed ID: 24465628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
